본문 바로가기
주메뉴 바로가기
뉴로바이오젠
ABOUT
Overview
History
CI
Affiliate Company
This is the way
BUSINESS
Vision & Motto
Pipeline
Tisolagiline(KDS2010)
COMMUNICATIONS
News
Announcements
R&D
Corporate R&D Center
Joint research Institute
IR
Announcement
Corporate Disclosure
CAREERS
Ideal Candidate
Employment Announce
ENG
KOR
ENG
COMMUNICATION
News
Announcements
News & Press Release
Neurobiogen. Obesity Treatment Phase 2 Clinical Trial Receives IND Approval from Ministry of Food an
DATE : 2024-09-04
VIEWS : 2240
FILES
PREV
100 Billion Won Investment Obesity Drug Enters Phase 2... Neurobiogen's Perseverance.
NEXT
Neurobiogen, Obesity Treatment Approved for Phase 2 Clinical Trial… “Speeding Up Innovative New Drug
LIST
Add
(06714) 2 FL, Bangbae BLDG, 9, Myeongdal-ro, Seocho-gu, Seoul, Republic of Korea
Tel
+82-70-4018-8009
Fax
+82-02-3486-2613
E-mail
neuro_reply@neurobiogen.com
FAMILY SITE
(주)시너지이노베이션
(주)메디카코리아
(주)프로톡스
(주)인트로바이오파마
(주)엠아이텍
노비스바이오(주)
COPYRIGHT ⓒ 2025 NEUROBIOGEN. All rights reserved